Eyeing Biotech, SoCal Investor Picks Up East Bay Tech Campus For $26M

Buchanan Street Partners has acquired a 99K SF Newark, California, complex for $26.2M, or about $262 per SF, with plans for significant upgrades to meet local life science and tech demand, the company said Tuesday.

8000 and 8100 Jarvis Ave.
Courtesy of Buchanan Street Partners
Buchanan Street Looks To Capitalize On Newark's Life Science Industry.

The two-building Newark Tech Park, located at 8000 and 8100 Jarvis Ave., holds tech and life sciences companies, and the latter building is due for full vacancy later this year, according to Buchanan Street Partners.

The Newport Beach, California-based investor grabbed the 99K SF Newark Tech Park from Time Equities, a developer out of New York City.

Newark, a more affordable alternative than the Peninsula for life sciences companies, has a growing footprint in the industry, highlighted by BioMed Realty's 1.4M SF Pacific Research Center.

Buchanan Street Partners Executive Vice President Bob Dougherty says it is very likely 8100 Jarvis ends up as home to one or two life sciences companies, with research space on the ground floor and office on the second floor.

"The primary thing that drew us to [Newmark Tech Park] was the opportunity to convert the emptying building to a life science asset," Dougherty told Bisnow, adding that its location near one end of the Dumbarton Bridge is another attractive feature.

"Everybody that we're talking to says there is much more demand than supply, and that the release valve from the Peninsula is very necessary," he said.

Average asking annual net rents for Newark R&D space came in at $29.04 last quarter, about half of what space on the other side of the bridge often fetches, according to Cushman & Wakefield.

Buchanan assumed an in-place CMBS loan on 8000 Jarvis St. and financed its acquisition of the adjacent building with a new loan. JLL Director Peter Thompson led financing efforts for the buyer.

Newmark Knight Frank Vice Chairman Grant Lammersen, Vice Chairman Steven Golubchik, Executive Managing Director Edmund Najera and Senior Managing Director Tyler Myerdirk represented Time Equities in its sale.

CORRECTION, Jan. 31, 7:34 P.M. PT: A previous version of this story misstated Buchanan Street Partners Executive Vice President Bob Dougherty's title. The story has been updated.

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's San Francisco Newsletters
Related Stories

Orchard Partners Selects JLL To Market 892K SF Manufacturing Campus In Brisbane: The San Francisco Deal Sheet

Foundry Robotics Leaves San Francisco For New East Bay HQ

Why Research Triangle Park Life Sciences Is Turning Toward Manufacturing And Flexible Spaces

Capital Flooded Into Bay Area Apartments. Then Treasury Yields Spiked

Alexandria Sells Stakes In Megacampuses To Weather Life Sciences Downturn

Data Centers Lose The Top Spot, San Francisco Jumps 40 Places: 9 Takeaways From ULI's 2027 Outlook

As The Future Of The Office Continues To Evolve, WeWork Is Bringing Clients A Tailored Workplace Solution

AI Safety Nonprofit Takes 82K SF At BlackRock's King's Cross Campus

JLL Sues Ex-Life Sciences Leader, Alleging Breach Of Noncompete

Hudson Pacific's Historic San Francisco Conversion Project Gets Approval

Elecor, Formerly Paramount Group, Gains New Muscle With Rithm In Its Corner

High Street Residential, Barings Break Ground On 501 Apartment Units In Redwood City